Cheng K F, Lin W J, Chen J H, Horng J T
Biostatistics Center and Department of Public Health, China Medical University, Taichung, Taiwan, ROC.
Hum Hered. 2009;68(4):278-87. doi: 10.1159/000228925. Epub 2009 Jul 22.
The performance of association tests based on case-control or case-parents substudy alone can be improved by jointly using genetic data from two substudies. However, genetic data from different sources may not be combinable due to population stratification. We propose a two-stage association test based on using combinability tests in stage 1 and association tests in stage 2.
The combinability tests are designed for testing that genotype data from different sources have same genotype frequencies and relative risks. The association tests are well known tests in the literature. We propose a method to adjust the significance levels at two stages so that the overall type I error rate of the two-stage test can be controlled at the desired level.
The simulation results confirm that the two-stage test has empirical type I error rates approximately equal to the predetermined levels while making substantially fewer false negatives than the usual test based only on case-parents substudy.
It is advantageous to combinecase-control and case-parents data into a single analysis.The two-stage test has significant power improvement when the family-based test has weak or moderate power performance and is robust to the effect of population stratification.
通过联合使用来自两个子研究的遗传数据,基于病例对照或病例-父母子研究单独进行的关联测试的性能可以得到提高。然而,由于群体分层,来自不同来源的遗传数据可能无法合并。我们提出了一种两阶段关联测试,第一阶段使用可合并性测试,第二阶段进行关联测试。
可合并性测试旨在检验来自不同来源的基因型数据是否具有相同的基因型频率和相对风险。关联测试是文献中已知的测试。我们提出了一种在两个阶段调整显著性水平的方法,以便将两阶段测试的总体I型错误率控制在期望水平。
模拟结果证实,两阶段测试的经验性I型错误率近似等于预定水平,同时与仅基于病例-父母子研究的常规测试相比,假阴性结果大幅减少。
将病例对照和病例-父母数据合并到单一分析中是有利的。当基于家系的测试具有较弱或中等的检验效能时,两阶段测试具有显著的效能提高,并且对群体分层的影响具有稳健性。